Cargando…
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer
BACKGROUND: Knowledge regarding cognitive problems in metastatic non-small cell lung cancer (mNSCLC) is limited. Such problems may include both patient-reported cognitive concerns and demonstrable cognitive impairment. Greater understanding of these outcomes is needed to inform rehabilitation strate...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789294/ https://www.ncbi.nlm.nih.gov/pubmed/35087675 http://dx.doi.org/10.1093/nop/npab056 |
_version_ | 1784639735519510528 |
---|---|
author | Eggen, Annemarie C Richard, Nadine M Bosma, Ingeborg Jalving, Mathilde Leighl, Natasha B Liu, Geoffrey Mah, Kenneth Higazy, Randa Shultz, David B Reyners, Anna K L Rodin, Gary Edelstein, Kim |
author_facet | Eggen, Annemarie C Richard, Nadine M Bosma, Ingeborg Jalving, Mathilde Leighl, Natasha B Liu, Geoffrey Mah, Kenneth Higazy, Randa Shultz, David B Reyners, Anna K L Rodin, Gary Edelstein, Kim |
author_sort | Eggen, Annemarie C |
collection | PubMed |
description | BACKGROUND: Knowledge regarding cognitive problems in metastatic non-small cell lung cancer (mNSCLC) is limited. Such problems may include both patient-reported cognitive concerns and demonstrable cognitive impairment. Greater understanding of these outcomes is needed to inform rehabilitation strategies for these difficulties. We aimed to identify the frequency of cognitive problems and associated factors in patients with mNSCLC. METHODS: In this cross-sectional study, adults with mNSCLC completed validated neuropsychological tests and self-report questionnaires measuring cognitive concerns, neurobehavioral concerns, depression, demoralization, illness intrusiveness, self-esteem, and physical symptoms. Cognitive impairment (performance based) was defined according to International Cancer and Cognition Task Force criteria. Clinically significant cognitive concerns were defined by a score ≥1.5 SD below the normative mean on the Functional Assessment of Cancer Therapy-Cognitive Function Perceived Cognitive Impairment (FACT-Cog PCI). Univariate and multivariate logistic regression analyses were performed to identify associated factors. RESULTS: Of 238 patients approached, 77 participated (median age: 62 years; range: 37-82). Brain metastases were present in 41 patients (53%), and 23 (29%) received cranial irradiation. Cognitive impairment and cognitive concerns were present in 31 (40%) and 20 patients (26%), respectively. Cognitive impairment and cognitive concerns co-occurred in 10 patients (13%), but their severity was unrelated. Cognitive impairment was associated with cranial irradiation (odds ratio [OR] = 2.89; P = .04), whereas cognitive concerns were associated with greater illness intrusiveness (OR = 1.04; P = .03) and lower self-esteem (OR = 0.86; P = .03). CONCLUSIONS: Cognitive impairment and cognitive concerns are both common in patients with mNSCLC but are not necessarily related, and their risk factors differ. The association of illness intrusiveness and self-esteem with cognitive concerns can inform therapeutic interventions in this population. |
format | Online Article Text |
id | pubmed-8789294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-87892942022-01-26 Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer Eggen, Annemarie C Richard, Nadine M Bosma, Ingeborg Jalving, Mathilde Leighl, Natasha B Liu, Geoffrey Mah, Kenneth Higazy, Randa Shultz, David B Reyners, Anna K L Rodin, Gary Edelstein, Kim Neurooncol Pract Original Articles BACKGROUND: Knowledge regarding cognitive problems in metastatic non-small cell lung cancer (mNSCLC) is limited. Such problems may include both patient-reported cognitive concerns and demonstrable cognitive impairment. Greater understanding of these outcomes is needed to inform rehabilitation strategies for these difficulties. We aimed to identify the frequency of cognitive problems and associated factors in patients with mNSCLC. METHODS: In this cross-sectional study, adults with mNSCLC completed validated neuropsychological tests and self-report questionnaires measuring cognitive concerns, neurobehavioral concerns, depression, demoralization, illness intrusiveness, self-esteem, and physical symptoms. Cognitive impairment (performance based) was defined according to International Cancer and Cognition Task Force criteria. Clinically significant cognitive concerns were defined by a score ≥1.5 SD below the normative mean on the Functional Assessment of Cancer Therapy-Cognitive Function Perceived Cognitive Impairment (FACT-Cog PCI). Univariate and multivariate logistic regression analyses were performed to identify associated factors. RESULTS: Of 238 patients approached, 77 participated (median age: 62 years; range: 37-82). Brain metastases were present in 41 patients (53%), and 23 (29%) received cranial irradiation. Cognitive impairment and cognitive concerns were present in 31 (40%) and 20 patients (26%), respectively. Cognitive impairment and cognitive concerns co-occurred in 10 patients (13%), but their severity was unrelated. Cognitive impairment was associated with cranial irradiation (odds ratio [OR] = 2.89; P = .04), whereas cognitive concerns were associated with greater illness intrusiveness (OR = 1.04; P = .03) and lower self-esteem (OR = 0.86; P = .03). CONCLUSIONS: Cognitive impairment and cognitive concerns are both common in patients with mNSCLC but are not necessarily related, and their risk factors differ. The association of illness intrusiveness and self-esteem with cognitive concerns can inform therapeutic interventions in this population. Oxford University Press 2021-09-07 /pmc/articles/PMC8789294/ /pubmed/35087675 http://dx.doi.org/10.1093/nop/npab056 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Articles Eggen, Annemarie C Richard, Nadine M Bosma, Ingeborg Jalving, Mathilde Leighl, Natasha B Liu, Geoffrey Mah, Kenneth Higazy, Randa Shultz, David B Reyners, Anna K L Rodin, Gary Edelstein, Kim Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer |
title | Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer |
title_full | Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer |
title_fullStr | Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer |
title_full_unstemmed | Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer |
title_short | Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer |
title_sort | factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789294/ https://www.ncbi.nlm.nih.gov/pubmed/35087675 http://dx.doi.org/10.1093/nop/npab056 |
work_keys_str_mv | AT eggenannemariec factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT richardnadinem factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT bosmaingeborg factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT jalvingmathilde factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT leighlnatashab factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT liugeoffrey factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT mahkenneth factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT higazyranda factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT shultzdavidb factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT reynersannakl factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT rodingary factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer AT edelsteinkim factorsassociatedwithcognitiveimpairmentandcognitiveconcernsinpatientswithmetastaticnonsmallcelllungcancer |